167 related articles for article (PubMed ID: 24417698)
1. Sodium cholate, a solubilizing agent for the necrosis avid radioiodinated hypericin in rabbits with acute myocardial infarction.
Cona MM; Feng Y; Zhang J; Li Y; Verbruggen A; Oyen R; Ni Y
Drug Deliv; 2015 May; 22(3):427-35. PubMed ID: 24417698
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of iodine-123-labeled hypericin and (99m)Tc-labeled hexakis [2-methoxy isobutyl isonitrile] in a rabbit model of myocardial infarction.
Cona MM; Feng Y; Li Y; Chen F; Vunckx K; Zhou L; Van Slambrouck K; Rezaei A; Gheysens O; Nuyts J; Verbruggen A; Oyen R; Ni Y
J Cardiovasc Pharmacol; 2013 Sep; 62(3):304-11. PubMed ID: 23714775
[TBL] [Abstract][Full Text] [Related]
3. Improvement of solubility and targetability of radioiodinated hypericin by using sodium cholate based solvent in rat models of necrosis.
Ji Y; Zhan Y; Jiang C; Jiang X; Gao M; Liu W; Li Y; Wang J; Wang Q; Cona MM; Yao N; Wang X; Fang Z; Yin Z; Zhang J; Sun Z; Ni Y
J Drug Target; 2014 May; 22(4):304-12. PubMed ID: 24328682
[TBL] [Abstract][Full Text] [Related]
4. Biodistribution and radiation dosimetry of radioiodinated hypericin as a cancer therapeutic.
Cona MM; Koole M; Feng Y; Liu Y; Verbruggen A; Oyen R; Ni Y
Int J Oncol; 2014 Mar; 44(3):819-29. PubMed ID: 24366374
[TBL] [Abstract][Full Text] [Related]
5. Targetability and biodistribution of radioiodinated hypericin: comparison between microdosing and carrier-added preparations.
Cona MM; Li J; Feng Y; Chen F; Verbruggen A; Witte Pd; Oyen R; Ni Y
Anticancer Agents Med Chem; 2014; 14(6):852-61. PubMed ID: 24102315
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and Preclinical Evaluation of Radioiodinated Hypericin Dicarboxylic Acid as a Necrosis Avid Agent in Rat Models of Induced Hepatic, Muscular, and Myocardial Necroses.
Li J; Zhang J; Yang S; Jiang C; Zhang D; Jin Q; Wang Q; Wang C; Ni Y; Yin Z; Song S
Mol Pharm; 2016 Jan; 13(1):232-40. PubMed ID: 26568406
[TBL] [Abstract][Full Text] [Related]
7. Radioiodinated hypericin: its biodistribution, necrosis avidity and therapeutic efficacy are influenced by formulation.
Cona MM; Alpizar YA; Li J; Bauwens M; Feng Y; Sun Z; Zhang J; Chen F; Talavera K; de Witte P; Verbruggen A; Oyen R; Ni Y
Pharm Res; 2014 Feb; 31(2):278-90. PubMed ID: 23934256
[TBL] [Abstract][Full Text] [Related]
8. Radioiodinated hypericin as a tracer for detection of acute myocardial infarction: SPECT-CT imaging in a swine model.
Yang S; Ma J; Li T; Wang P; Wang X; Zhang J; Ni Y; Shao H
J Nucl Cardiol; 2022 Dec; 29(6):3432-3439. PubMed ID: 35296972
[TBL] [Abstract][Full Text] [Related]
9. First preclinical evaluation of mono-[123I]iodohypericin as a necrosis-avid tracer agent.
Ni Y; Huyghe D; Verbeke K; de Witte PA; Nuyts J; Mortelmans L; Chen F; Marchal G; Verbruggen AM; Bormans GM
Eur J Nucl Med Mol Imaging; 2006 May; 33(5):595-601. PubMed ID: 16450141
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of hypericin: effect of aggregation on targeting biodistribution.
Liu X; Jiang C; Li Y; Liu W; Yao N; Gao M; Ji Y; Huang D; Yin Z; Sun Z; Ni Y; Zhang J
J Pharm Sci; 2015 Jan; 104(1):215-22. PubMed ID: 25395358
[TBL] [Abstract][Full Text] [Related]
11. Effects of skeleton structure on necrosis targeting and clearance properties of radioiodinated dianthrones.
Zhang D; Jiang C; Yang S; Gao M; Huang D; Wang X; Shao H; Feng Y; Sun Z; Ni Y; Zhang J; Yin Z
J Drug Target; 2016; 24(6):566-77. PubMed ID: 26586010
[TBL] [Abstract][Full Text] [Related]
12. Preparation and validation of cyclodextrin-based excipients for radioiodinated hypericin applied in a targeted cancer radiotherapy.
Li Y; Wang S; Jiang X; Wang X; Zhou X; Wan L; Zhao H; Zhou Z; Gao L; Huang G; Ni Y; He X
Int J Pharm; 2021 Apr; 599():120393. PubMed ID: 33639227
[TBL] [Abstract][Full Text] [Related]
13. Radiopharmaceutical evaluation of (131)I-protohypericin as a necrosis avid compound.
Liu X; Feng Y; Jiang C; Lou B; Li Y; Liu W; Yao N; Gao M; Ji Y; Wang Q; Huang D; Yin Z; Sun Z; Ni Y; Zhang J
J Drug Target; 2015 Jun; 23(5):417-26. PubMed ID: 25655506
[TBL] [Abstract][Full Text] [Related]
14. Discovery of Radioiodinated Monomeric Anthraquinones as a Novel Class of Necrosis Avid Agents for Early Imaging of Necrotic Myocardium.
Wang Q; Yang S; Jiang C; Li J; Wang C; Chen L; Jin Q; Song S; Feng Y; Ni Y; Zhang J; Yin Z
Sci Rep; 2016 Feb; 6():21341. PubMed ID: 26878909
[TBL] [Abstract][Full Text] [Related]
15. Necrosis affinity evaluation of 131I-hypericin in a rat model of induced necrosis.
Kong M; Zhang J; Jiang C; Jiang X; Li Y; Gao M; Yao N; Huang D; Wang X; Fang Z; Liu W; Sun Z; Ni Y
J Drug Target; 2013 Jul; 21(6):604-10. PubMed ID: 23627568
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Necrosis Avidity and Potential for Rapid Imaging of Necrotic Myocardium of Radioiodinated Hypocrellins.
Jin Q; Zhao J; Gao M; Feng Y; Liu W; Yin Z; Li T; Song S; Ni Y; Zhang J; Huang D; Zhang D
Mol Imaging Biol; 2018 Aug; 20(4):551-561. PubMed ID: 29305726
[TBL] [Abstract][Full Text] [Related]
17. Radioiodinated hypericin disulfonic acid sodium salts as a DNA-binding probe for early imaging of necrotic myocardium.
Duan X; Yin Z; Jiang C; Jin Q; Zhang D; Sun Z; Ye W; Zhang J
Eur J Pharm Biopharm; 2017 Aug; 117():151-159. PubMed ID: 28414189
[TBL] [Abstract][Full Text] [Related]
18. Improved therapeutic outcomes of thermal ablation on rat orthotopic liver allograft sarcoma models by radioiodinated hypericin induced necrosis targeted radiotherapy.
Gao L; Zhang J; Ma T; Yao N; Gao M; Shan X; Ni Y; Shao H; Xu K
Oncotarget; 2016 Aug; 7(32):51450-51461. PubMed ID: 27285983
[TBL] [Abstract][Full Text] [Related]
19. Non-invasive detection and quantification of acute myocardial infarction in rabbits using mono-[123I]iodohypericin microSPECT.
Fonge H; Vunckx K; Wang H; Feng Y; Mortelmans L; Nuyts J; Bormans G; Verbruggen A; Ni Y
Eur Heart J; 2008 Jan; 29(2):260-9. PubMed ID: 18156139
[TBL] [Abstract][Full Text] [Related]
20. Biodistribution and anti-tumor efficacy of intratumorally injected necrosis-avid theranostic agent radioiodinated hypericin in rodent tumor models.
Liu W; Zhang D; Feng Y; Li Y; Huang D; Jiang C; Gao M; Peng F; Wang X; Jing S; Jiang X; Ni Y; Zhang J
J Drug Target; 2015 May; 23(4):371-9. PubMed ID: 25572455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
